510(k) · Cleared
ClearedDimension Vista B2MIC Flex Reagent Cartridge, Protein 1 Calibrator, Control Medium, Control High
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Dade Behring, Inc. · JZG System, Test, Beta-2-Microglobulin Immunological
Cleared on Jan 26, 2007 as substantially equivalent to K002731 (Dade Behring, Inc., 2000) and 2 other predicates after an 88-day review. Its family tree reaches back 2 generations to 2000.
- Decided
- Jan 26, 2007
- Review
- 88 days
- Class
- Class II
- Product code
- JZG
- Recalls
- None
- Predicates
- 3
Its longest line of descent runs back 2 generations to K002852 (2000). 5 ancestors in all, the oldest K002804 (2000). No later device cites it as a predicate yet.
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −2 | K002852 | N/T Protein Control SL | Dade Behring, Inc. | 2000 | — |
| −1 | K012468 | Modification to N/T Protein Control SL | Dade Behring, Inc. | 2001 | — |
| 0 (this device) | K063272 | Dimension Vista B2MIC Flex Reagent Cartridge, Protein 1 Calibrator, Control… | Dade Behring, Inc. | 2007 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2000 | 2 | 0 |
| 2001 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in JZG? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
- Candidate predicates for a device like this, rankedin the report
- Recall history across each candidate’s familyin the report
What was it cleared against? (3)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K002731 | N Latex B2-MicroglobulinSummary page 1…Immunology (82) and Clinical Chemistry (75) 3. Identification of the Legally Marketed Device: Dade Behring N Latex f32-Microglobulin - K002731 Dade Behring N Protein Standard SL - K012470 Dade Behring N/T Protein Control SL - K012468… | 2000 |
| * | K012470 | Modification to N Protein Standard SLSummary page 1…(75) 3. Identification of the Legally Marketed Device: Dade Behring N Latex f32-Microglobulin - K002731 Dade Behring N Protein Standard SL - K012470 Dade Behring N/T Protein Control SL - K012468… | 2001 |
| * | K012468 | Modification to N/T Protein Control SLSummary page 1…Device: Dade Behring N Latex f32-Microglobulin - K002731 Dade Behring N Protein Standard SL - K012470 Dade Behring N/T Protein Control SL - K012468 ((10 Viii Dade… | 2001 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 7 years and passes through 1 company; a new generation was cleared every 5.4 years on median.
- 1 of the 5 ancestors has a recall of any class.
- 2 other devices also cite its predicate K002731.
How does its category compare?
All JZG devicesJZG System, Test, Beta-2-Microglobulin Immunological: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.
FDA decisions per year · JZG
1in 2016
2026 to Oct 25, outlined.
Median 510(k) review, days · JZG
Too few JZG 510(k)s in any year since 2007 to give a median.
Recalls per year · JZG
1in 2024
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · JZG
1in 2024
MAUDE reports naming product code JZG, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 2 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 2 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 2 | — | 0 | 0 |
| 2013 | 0 | — | 0 | 0 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 0 | — | 1 | 50 |
| 2016 | 1 | — | 0 | 0 |
| 2017 | 0 | — | 0 | 0 |
| 2018 | 0 | — | 0 | 0 |
| 2019 | 0 | — | 0 | 1 |
| 2020 | 0 | — | 0 | 0 |
| 2021 | 0 | — | 1 | 0 |
| 2022 | 0 | — | 0 | 0 |
| 2023 | 0 | — | 0 | 0 |
| 2024 | 0 | — | 1 | 1 |
| 2025 | 0 | — | 0 | 0 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
The B2MIC method is an in vitro diagnostic test for the quantitative determination of β2-microglobulin in human serum, or heparinized or EDTA plasma on the Dimension Vista® System. Measurements of β2-microglobulin aid in the diagnosis of renal dysfunction. PROT1 CAL is an in vitro diagnostic product for the calibration of the β2-microglobulin (B2MIC), C3 Complement (C3), C4 Complement (C4), Immunoglobulin A (IGA), Immunoglobulin G (IGG), Immunoglobulin M…
Read the full statement (127 words)
The B2MIC method is an in vitro diagnostic test for the quantitative determination of β2-microglobulin in human serum, or heparinized or EDTA plasma on the Dimension Vista® System. Measurements of β2-microglobulin aid in the diagnosis of renal dysfunction.
PROT1 CAL is an in vitro diagnostic product for the calibration of the β2-microglobulin (B2MIC), C3 Complement (C3), C4 Complement (C4), Immunoglobulin A (IGA), Immunoglobulin G (IGG), Immunoglobulin M (QGM) and Prealbumin / Transthyretin (PREALB) methods on the Dimension Vista System.
PROT1 CON M and H are assayed intralaboratory quality controls for assessment of precision and analytical bias in the determination of β2-microglobulin (B2MIC), C3 Complement (C3), C4 Complement (C4), immunoglobulin A (IGA), immunoglobulin G (IGG), immunoglobulin M (IGM) and prealbumin / transthyretin (PREALB) on the Dimension Vista® System.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K063272 · printed Nov 4, 2026
Cite this page
510(k) Report. “K063272: Dimension Vista B2MIC Flex Reagent Cartridge, Protein 1 Calibrator, Control Medium, Control High.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K063272
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026